The activities of the Let’s Talk Prostate Cancer (LTPC) Expert Group are funded by Astellas Pharma Inc., Agen Inc and Pfizer Inc, which collectively contribute to and support the objectives of the Expert group.
Astellas Pharma Inc. have full and exclusive editorial control over the LTPC Website

The Let’s Talk Prostate Cancer Digital Atlas

The Let’s Talk Prostate Cancer (LTPC) Digital Atlas provides an overview of prostate cancer outcomes across the EU and for each of the EU 27 countries and the UK. The assumption that men with prostate cancer die with, rather than of prostate cancer, is a common misconception.1 Prostate cancer is a major health challenge with over 2 million people living with the disease across Europe, causing an estimated 107,000 deaths in 2018 alone.2,3 The time to act is now.

Screenshot (7)

LTPC Resources

We have developed a number of policy recommendations
showing how care for the patient community could be improved.

Recommendations (1)

Prioritisation, health inequalities, and EU Guidance implementation.

Campaign Materials (1)
Digital Atlas Materials

Articles, Call to Action, COVID-19 paper

Statistics (1)

Incidence, Morality, Survival, Prostate Cancer Care, Quality of Life


Our Expert Group

The Supporters


Links to external websites are provided as a resource to the viewer. We accept no responsibility for the content or services of the linked site other than the information or other materials provided or reviewed by the LTPC expert group members 

1 Prostate Cancer UK. Separating fact from fiction: revealing the truth behind common prostate cancer myths. Accessible at https://prostatecanceruk.org/about-us/news-and-views/2019/7/prostate-cancer-mythbusting (last accessed October 2023)
2 Van Poppel, H et al. Prostate Cancer: Recommendations to lower the risk and mortality of the most frequent cancer in men. European Association of Urology. 2018. Accessible at https://uroweb.org/wp-content/uploads/EAU_WhitePaper_PCa_final.pdf (last accessed October 2023)
3 Van Poppel, H et al. Policy Paper on PSA Screening for Prostate Cancer. European Association of Urology. 2019. Accessible at http://epad.uroweb.org/wp-content/uploads/EAU_policy-briefing_PSA.pdf (last accessed October 2023)